Abstract on autophagy, cellular senescence and brain aging, with proposed intermittent fasting links
This abstract describes how cellular senescence and declining autophagy relate to brain aging and outlines proposed pathways by which intermittent fasting might induce autophagy; it reports no new experiments, and responses and ideal fasting duration remain uncertain. [1]
Automatic summary · not editorially reviewed
The key findings
The abstract states that cellular senescence is a hallmark of biological aging and plays a crucial role in the development of neurodegenerative diseases. [1]
The abstract states that autophagy is compromised with increasing age. [1]
The abstract proposes that intermittent fasting may modulate autophagy via ATP/ADP changes activating AMPK and Sirtuin 1 while inhibiting mTOR, but notes variable responses and an uncertain ideal fasting duration. [1]
The source at a glance
- Study type / format
- Abstract of a narrative review or conceptual discussion (design not specified in the abstract)
- Population / context
- General discussion of aging cells and age-related neurodegenerative disease; no specific human or animal population is described.
- Summary based on
- Study abstract
- Original publication
- March 11, 2026
Senescence, autophagy and age-related brain disease
The abstract states that aging involves progressive loss of cellular function and molecular integrity, raising vulnerability to age-related diseases such as neurodegenerative disorders. It calls cellular senescence a hallmark of biological aging that plays a crucial role in the development of neurodegenerative diseases. Autophagy, described as a lysosome-mediated degradation process, is said to be crucial for cellular homeostasis and longevity and for removing sequestered proteins and damaged organelles. With increasing age, autophagy is described as compromised. These are stated relationships, not results of a new experiment reported here.
Supporting source [1]
Proposed fasting pathways via AMPK, Sirtuin 1 and mTOR
According to the abstract, intermittent fasting consists of cycles of fasting and normal feeding and has been recognized as a potential method to induce autophagy and obtain health benefits. It is proposed to modulate autophagy by changing ATP and ADP levels during fasting, activating pathways such as AMPK and Sirtuin 1, which promote autophagosome formation, while inhibiting mTOR, described as an inhibitor of autophagy. The abstract presents these as potential mechanisms, not as demonstrated human outcomes.
Supporting source [1]
Uncertain fasting responses and unknown optimal duration
The abstract notes constraints despite encouraging properties of intermittent fasting: responses may vary considerably among subjects, and the ideal duration of fasting is uncertain. It also states that the potential for new metabolic diseases associated with intermittent fasting is not fully understood. It concludes that understanding the relationships among aging, autophagy and dietary restrictions such as intermittent fasting could support novel therapeutic strategies to increase longevity and mitigate age-related health issues; this is a future prospect, not a demonstrated benefit.
Supporting source [1]
How to interpret this
This is an abstract only; the full text was not reviewed. No study design, sample, follow-up or measured outcomes are reported, so the described mechanisms and potential benefits are not established by this source.
Based on the study abstract; the full paper, tables and supplementary data were not reviewed.
Source & supporting passages
Singh I, Bhat S, Tamatta R, Singh AK. · europepmc.org · March 11, 2026